MEX3A and ovarian carcinoma: Furthermore, qRT-PCR and western blotting were used to evaluate TIMELESS expression after MEX3A knockdown in ovarian cancer cells, and we found that TIMELESS mRNA and protein expression was obviously decreased after MEX3A inhibition (Fig. 4I, J).